Bruce Colwill is CFO of InMed Pharmaceuticals Inc.. Currently has a direct ownership of 11,515 shares of INM, which is worth approximately $2,993. The most recent transaction as insider was on Jan 24, 2022, when has been sold 5,000 shares (Common Stock) at a price of $1.09 per share, resulting in proceeds of $5,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.5K
0% 3M change
0% 12M change
Total Value Held $2,993

BRUCE COLWILL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2022
BUY
Open market or private purchase
$5,450 $1.09 p/Share
5,000 Added 30.28%
11,515 Common Stock
Sep 28 2021
BUY
Open market or private purchase
$8,850 $1.77 p/Share
5,000 Added 43.42%
6,515 Common Stock
BC

Bruce Colwill

CFO
Vancouver, A1

Track Institutional and Insider Activities on INM

Follow InMed Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INM shares.

Notify only if

Insider Trading

Get notified when an In Med Pharmaceuticals Inc. insider buys or sells INM shares.

Notify only if

News

Receive news related to InMed Pharmaceuticals Inc.

Track Activities on INM